| Clinical impact of programmed cell death ligand 1 expression in colorectal cancer RA Droeser, C Hirt, CT Viehl, DM Frey, C Nebiker, X Huber, I Zlobec, ... European journal of cancer 49 (9), 2233-2242, 2013 | 512 | 2013 |
| Phase I study in melanoma patients of a vaccine with peptide‐pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells A Mackensen, B Herbst, JL Chen, G Köhler, C Noppen, W Herr, ... International journal of cancer 86 (3), 385-392, 2000 | 504 | 2000 |
| Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study S Ghosh, GC Spagnoli, I Martin, S Ploegert, P Demougin, M Heberer, ... Journal of cellular physiology 204 (2), 522-531, 2005 | 437 | 2005 |
| Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints I Martin, M Jakob, D Schäfer, W Dick, G Spagnoli, M Heberer Osteoarthritis and Cartilage 9 (2), 112-118, 2001 | 402 | 2001 |
| Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer A Lugli, G Iezzi, I Hostettler, MG Muraro, V Mele, L Tornillo, V Carafa, ... British journal of cancer 103 (3), 382-390, 2010 | 365 | 2010 |
| Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 S Manici, T Sturniolo, MA Imro, J Hammer, F Sinigaglia, C Noppen, ... The Journal of experimental medicine 189 (5), 871-876, 1999 | 341 | 1999 |
| IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector … E Padovan, GC Spagnoli, M Ferrantini, M Heberer Journal of leukocyte biology 71 (4), 669-676, 2002 | 322 | 2002 |
| Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. A Funaro, GC Spagnoli, CM Ausiello, M Alessio, S Roggero, D Delia, ... Journal of immunology (Baltimore, Md.: 1950) 145 (8), 2390-2396, 1990 | 318 | 1990 |
| Modulation of T-cell activation by malignant melanoma initiating cells T Schatton, U Schütte, NY Frank, Q Zhan, A Hoerning, SC Robles, J Zhou, ... Cancer research 70 (2), 697-708, 2010 | 312 | 2010 |
| Expression of MAGE‐antigens in normal tissues and cancer AA Jungbluth, KJ Busam, D Kolb, K Iversen, K Coplan, YT Chen, ... International journal of cancer 85 (4), 460-465, 2000 | 310 | 2000 |
| Genes encoding tumor-specific antigens are expressed in human myeloma cells N van Baren, F Brasseur, D Godelaine, G Hames, A Ferrant, F Lehmann, ... Blood, The Journal of the American Society of Hematology 94 (4), 1156-1164, 1999 | 275 | 1999 |
| Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogeneic-stimulated … C Bocelli-Tyndall, L Bracci, G Spagnoli, A Braccini, M Bouchenaki, ... Rheumatology 46 (3), 403-408, 2007 | 242 | 2007 |
| NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses F Van Rhee, SM Szmania, F Zhan, SK Gupta, M Pomtree, P Lin, ... Blood 105 (10), 3939-3944, 2005 | 240 | 2005 |
| Gut microbiota modulate T cell trafficking into human colorectal cancer E Cremonesi, V Governa, JFG Garzon, V Mele, F Amicarella, MG Muraro, ... Gut 67 (11), 1984-1994, 2018 | 231 | 2018 |
| Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment S Däster, N Amatruda, D Calabrese, R Ivanek, E Turrini, RA Droeser, ... Oncotarget 8 (1), 1725, 2017 | 218 | 2017 |
| Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer U Guller, P Zajac, A Schnider, B Bösch, S Vorburger, M Zuber, ... Annals of surgery 236 (6), 768-776, 2002 | 214 | 2002 |
| The interplay between neutrophils and CD8+ T cells improves survival in human colorectal cancer V Governa, E Trella, V Mele, L Tornillo, F Amicarella, E Cremonesi, ... Clinical Cancer Research 23 (14), 3847-3858, 2017 | 197 | 2017 |
| Identification and intracellular location of MAGE-3 gene product T Kocher, E Schultz-Thater, F Gudat, C Schaefer, G Casorati, A Juretic, ... Cancer research 55 (11), 2236-2239, 1995 | 181 | 1995 |
| Microtubule-depolymerizing agents used in antibody–drug conjugates induce antitumor immunity by stimulation of dendritic cells P Müller, K Martin, S Theurich, J Schreiner, S Savic, G Terszowski, ... Cancer immunology research 2 (8), 741-755, 2014 | 165 | 2014 |
| Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms E Yakirevich, E Sabo, O Lavie, S Mazareb, GC Spagnoli, MB Resnick Clinical cancer research 9 (17), 6453-6460, 2003 | 165 | 2003 |
